SAN CARLOS, Calif.-- October 14, 2026 -- Altay Therapeutics, Inc., a biotechnology company developing novel small molecule inhibitors of transcription factors, today announced the completion of a $37 million Series...
Art Pappas will moderate the panel "Driving Innovation from a VC Perspective" at the BioExec Institute Retreat in Florida on March 21, 2013.
News | 03. 21. 2013
Art Pappas will moderate a panel titled, "Driving Innovation from a VC Perspective" at the BioExec Institute Retreat in Florida on March 21, 2013.
